Melanotan II (MT-II) is a cyclic lactam-bridged heptapeptide analogue of α-MSH studied as a potent non-selective agonist across MC1R, MC3R, MC4R, and MC5R melanocortin signaling pathways.
Scientific Profile & Research Key Points: Melanotan II
Melanotan II (MT-II) is a cyclic lactam-bridged heptapeptide analogue of α-MSH studied as a potent non-selective agonist across MC1R, MC3R, MC4R, and MC5R melanocortin signaling pathways.
Active Batch Release Specifications (Lot SL-2026-145)
Analytical release verification for current Melanotan II (10 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-145 | 2026-10-28 | RP-HPLC (C18, 214nm) + ESI-MS | ≥99.0% (Single Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL)
Temperature & Stability
Store lyophilized at -20°C shielded from light; refrigerate solution at 2°C–8°C for up to 28 days.
Melanotan II — Technical Questions & Answers
What is the molar concentration when reconstituting Melanotan II (10 mg) in 2.0 mL?
Reconstituting the full 10 mg vial of Melanotan II (MW 1024.18 g/mol) in 2.0 mL of diluent produces a 5.00 mg/mL stock solution — equivalent to approximately 4.88 mM (4,882 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does Melanotan II's counterion stoichiometry affect assay mass calculations?
Melanotan II (CAS 121062-08-6, formula C50H69N15O9) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify Melanotan II Lot SL-2026-145 and what pathway does it target?
Lot SL-2026-145 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 1024.18 g/mol. In preclinical literature, Melanotan II targets Pan-Melanocortin Receptors (MC1R, MC3R, MC4R, MC5R) (Al-Obeidi F. et al., J Med Chem (1989) — Potent cyclic lactam melanotropin analogue MT-II (PMID: 2555512)).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
Melanotan II: Cyclic Lactam Architecture, Melanocortin Receptor Subtypes, and Potency
A structural review of cyclic heptapeptide Melanotan II (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2). Receptor affinities (MC1R–MC5R), cyclic lactam stability, and analytical standards.
How to Read a Peptide Certificate of Analysis (COA): Step-by-Step Breakdown
A practical guide for researchers. How to analyze HPLC chromatograms, verify retention time, interpret mass spec m/z peaks, evaluate counterion salt ratios, and spot fraudulent documents.
How to Reconstitute Research Peptides: Complete Laboratory Protocol and Best Practices
Standard Operating Procedure (SOP) for peptide reconstitution. Diluent selection (BAC water vs acetic acid), meniscus calculations, avoiding foaming, and cold storage parameters.